Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:Q86TM3 (cage)
 29,987 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Reduction of the tethered carborane 1,2-(CH2)3-1,2-closo-C2B10H10 followed by treatment with CoCl2/NaCp, [(p-cymene)RuCl2]2(p-cymene=C6H4MeiPr-1,4), (PMe2Ph)2PtCl2 or (dppe)NiCl2(dppe=Ph2PCH2CH2PPh2) affords reasonable yields of the new 13-vertex metallacarboranes 1,2-(CH2)3-4-Cp-4,1,2-closo-CoC2B10H10 (1), 1,2-(CH2)3-4-(p-cymene)-4,1,2-closo-RuC2B10H10 (2), 1,2-(CH2)3-4,4-(PMe2Ph)2-4,1,2-closo-PtC2B10H10 (3) and 1,2-(CH2)3-4,4-(dppe)-4,1,2-closo-NiC2B10H10 (4), respectively. All compounds were characterised spectroscopically and crystallographically. The cobalt and ruthenium species 1 and 2 have Cs symmetry in both solution and the solid state, having henicosahedral cage structures featuring a trapezoidal C1C2B9B5 face. The platinum and nickel compounds 3 and 4 have asymmetric docosahedral cage structures in the crystal (the more so for 4 than for 3) although both appear, by 11B and 31P NMR spectroscopy, to have Cs symmetry in solution. Low-temperature experiments on the more soluble platinacarborane could not freeze out the diamond-trapezium-diamond fluctional process that we assume is operating in solution, and we therefore conclude that this process has a relatively low activation barrier, probably <35 kJ mol-1.
 ...
PMID:The synthesis and characterisation of 4,1,2-MC2B10 metallacarboranes. 1587 56

Reduction of boron-substituted carboranes o-R2C2B10Me8H2 (R = H, Et), thermal isomerization, and nucleophilic reaction of the resultant 13-vertex cobaltacarboranes were studied. Reaction of o-C2B10Me8H4 (1) with excess potassium metal in tetrahydrofuran (THF) gave, after recrystallization from a THF solution of 18-crown-6 ether, [[K(18-crown-6)(THF)2][K(18-crown-6)]][[4-(18-crown-6)-2,3,5,8,9,11,12,13-Me8-4,1,6-KC2B10H4]2] (2) in 78% yield. Interaction of 1 with excess sodium or potassium metal in THF, followed by treatment with CoCl2/CpNa and then aerobatic oxidation, afforded two boron-substituted 13-vertex cobaltacarboranes, 4-Cp-2,3,5,8,9,11,12,13-Me8-4,1,6-CoC2B10Me8H4 (3) and 4-Cp-2,3,5,9,10,11,12,13-Me8-4,1,6-CoC2B10Me8H4 (4), in 15% and 8% yield, respectively. Subsequently, thermal isomerization of 3 and 4 yielded another two new isomers, 4-Cp-2,3,5,6,8,11,12,13-Me8-4,1,9-CoC2B10Me8H4 (5) and 4-Cp-2,3,5,6,7,11,12,13-Me8-4,1,9-CoC2B10Me8H4 (6). Treatment of 3 or 4 with strong bases such as nBuLi and MeLi generated unexpected nucleophilic substitution products 4-nBuCp-2,3,5,8,9,11,12,13-Me8-4,1,6-CoC2B10Me8H4 (7), 4-nBuCp-2,3,5,9,10,11,12,13-Me8-4,1,6-CoC2B10Me8H4 (8a), and 4-MeCp-2,3,5,9,10,11,12,13-Me8-4,1,6-CoC2B10Me8H4 (8b) in good yields. Under the same reaction conditions, however, only one 13-vertex cobaltacarborane, 4-Cp-1,9-Et2-2,5,6,7,8,11,12,13-Me8-4,1,9-CoC2B10Me8H4 (10), was isolated when o-Et2C2B10Me8H2 (9) was used as the starting material. Complex 10 is a thermodynamically stable product and has a substitution pattern different from that of 3-6. These results show that the substituents on either the cage carbon or boron atoms have an important effect on the formation and thermal stability of the 13-vertex metallacarboranes. The formation of these complexes can be rationalized by the diamond-square-diamond mechanism.
 ...
PMID:Synthesis, structure, reactivity, and thermal isomerization of boron-substituted 13-vertex cobaltacarboranes (eta5-Cp)Co(eta6-R2C2B10Me8H2) (R = H, Et). 1734 77

We hypothesized that dorsomedial hypothalamus (DMH) modulates autonomic and neuroendocrine responses in rats at rest and when subjected to restraint stress (RS). Male Wistar rats were used, and guide cannulas were bilaterally implanted in the DMH for microinjection of vehicle or the nonspecific synaptic blocker CoCl2 (1 mM/100 nl). A polyethylene catheter was inserted into the femoral artery for the recording of arterial pressure and heart rate (HR). Tail temperature was measured using a thermal camera. The session of RS started 10 min after DMH treatment with vehicle or CoCl2. Under home-cage condition, the pretreatment of DMH with CoCl2 increased baseline blood pressure (BP), and heart rate (HR) without affecting the tail temperature. In addition, it decreased plasma vasopressin levels without affecting plasma corticosterone and oxytocin contents. When rats pretreated with CoCl2 were exposed to RS, the RS-evoked cardiovascular were similar to those observed in vehicle-treated animals; however, because cobalt pretreatment of the DMH increased baseline BP and HR values, and the RS-evoked cardiovascular responses did not exceed those observed in vehicle-treated animals, suggesting a possible celling limit, the possibility that DMH is involved in the modulation of RS-evoked cardiovascular responses cannot be certainly excluded. Nonetheless, the pretreatment of DMH with CoCl2 blocked the reduction in tail temperature caused by RS. The DMH pretreatment with CoCl2 did not modify the RS-evoked increase in plasma corticosterone and oxytocin contents. In conclusion, the present data suggest the involvement of DMH in the maintenance of BP, HR, and vasopressin release under the rest conditions at the home-cage. Furthermore, indicate that DMH is an important thermoregulatory center during exposure to RS, regulating tail artery vasoconstriction.
 ...
PMID:The Dorsomedial Hypothalamus Is Involved in the Mediation of Autonomic and Neuroendocrine Responses to Restraint Stress. 3203 36